Pharmacy Benefit Management Institute (PBMI) helps industry professionals manage pharmacy benefit programs through research-based drug benefit education.

2010 PBMI Drug Benefit Conference

Friday, February 19, 2010

7:45 am to 8:30 am
Continental Breakfast – Educational Forum Café

8:30 am to 8:45 am
Opening Remarks and General Session

8:45 am to 9:45 am
Behavioral Impact of Evidence-based Drug Plan Design
Asif Ally RPh, Vice President of Marketing, CVS Caremark
Sandra G. Morris, Senior Manager of U.S. Benefits Design, Procter & Gamble
ACPE UAN 221-999-10-009-L04-P 1.0 Knowledge-Based contact hours

This Procter & Gamble case study examines behavioral impact from an evidence-based drug plan design that lowered plan participant out-of-pocket costs by 50% for medications with proven clinical value in managing four common conditions. The study measures adherence as medication possession ratio, resource consumption as the number of participants using medication, and gaps in care as compliance with therapy guidelines.

Learning Objectives:

Identify the barriers and value of medication adherence.
Discuss how Evidence-based Plan Design (EBPD) affected the number plan participants engaged in therapy to treat diabetes, asthma, hypertension and high cholesterol.
Evaluate how the plan design influenced participant behavior to effect adherence and gaps in care.

9:45 am to 10:00 am
Break – Educational Forum Café

10:00 am to 11:00 am
Strengths and Weaknesses of the Latest Trends in Drug Benefit Plan Design
Moderator: Tim Watson, PharmD, Principal, Pharmacy Benefit Management Institute

Panelists:
Paula A..Bragg, Director, Piedmont Community HealthCare Alliance
Keith Bruhnsen,Assistant Director, Benefits Office and Manager, Prescription Drug Plan, University of Michigan
Ron Laudel, Benefits Plan Administrator, Carpenters Health & Welfare Trust Fund of St. Louis
ACPE UAN 221-999-10-010-L04-P 1.0 Knowledge-Based contact hours

A sound plan design helps plan sponsors control drug costs and optimize drug mix. Participate in this interactive session to discuss the strengths and weaknesses of several commonly used plan designs.

Learning Objectives:

Present three commonly used drug benefit plan designs for analysis.
Discuss strengths and weaknesses of each plan design.
Identify plan design strategies to help plan sponsors control drug costs and optimize drug mix.

11:00 am to 11:15 am
Final Comments
Conference Adjourns

Wednesday, February 17 | Thursday, February 18 | Conference Home